Skip to main content
. 2013 Jan 1;9(1):122–124. doi: 10.4161/hv.22317

Table 2. Solicited reactions (n = 7565).

Adverse reactions Frequency (N) % 95% CI
Mean duration in days (SD)*
Lower Upper
Runny nose
24
0.32
0.20%
0.47%
2.17 (1.74)
Stuffy nose
2
0.03
0.00%
0.1%
2.0 (2.41)
Sneezing
8
0.11
0.05%
0.21%
3.75 (3.33)
Nasal discomfort
13
0.17
0.09%
0.29%
2.46 (1.43)
Lacrimation
2
0.03
0.0%
0.1%
2.0 (2.83)
Sore throat
2
0.03
0.0%
0.1%
1.5 (0.71)
Loss of smell
1
0.01
0.0%
0.07%
3
Arthralgia
1
0.01
0.0%
0.07%
1
Chills
1
0.01
0.0%
0.07%
4
Cough
4
0.05
0.01%
0.14%
3.0 (0.82)
Fatigue
1
0.01
0.0%
0.07%
1
Fever
10
0.13
0.06%
0.24%
2.5 (0.92)
Headache
8
0.11
0.05%
0.21%
1.75 (1.16)
Irritability
1
0.01
0.0%
0.07%
1
Myalgia
1
0.01
0.0%
0.07%
1
Wheezing 2 0.03 0.0% 0.1% 1.0 (1.41)